The clustering of samples in relation to the miRNA expression uncovered the molecular similarity of Luminal BrCa molecular subtypes and a high miRNA molecular heterogeneity of the HER2-positive and triple-negative subtypes. This evidence concerns the gene ERBB2 and invasive breast carcinoma.